Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease.
Varcoe RL, DeRubertis BG, Kolluri R, Krishnan P, Metzger DC, Bonaca MP, Shishehbor MH, Holden AH, Bajakian DR, Garcia LA, Kum SWC, Rundback J, Armstrong E, Lee JK, Khatib Y, Weinberg I, Garcia-Garcia HM, Ruster K, Teraphongphom NT, Zheng Y, Wang J, Jones-McMeans JM, Parikh SA; LIFE-BTK Investigators. Varcoe RL, et al. Among authors: armstrong e. N Engl J Med. 2024 Jan 4;390(1):9-19. doi: 10.1056/NEJMoa2305637. Epub 2023 Oct 25. N Engl J Med. 2024. PMID: 37888915 Clinical Trial.
Evaluation of an Infrapopliteal Drug-Eluting Resorbable Scaffold: Design Methodology for the LIFE-BTK Randomized Controlled Trial.
Varcoe RL, Parikh SA, DeRubertis BG, Jones-McMeans JM, Teraphongphom NT, Wang J, Kolluri R, Weinberg I, Holden AH, Garcia-Garcia HM, Kum SWC, Bonaca MP, Bajakian DR, Garcia LA, Krishnan P, Armstrong E, Shishehbor MH, Rundback J, Metzger DC. Varcoe RL, et al. Among authors: armstrong e. J Soc Cardiovasc Angiogr Interv. 2023 May 19;2(4):100964. doi: 10.1016/j.jscai.2023.100964. eCollection 2023 Jul-Aug. J Soc Cardiovasc Angiogr Interv. 2023. PMID: 39131658 Free PMC article.
Orbital atherectomy versus balloon angioplasty before drug-eluting stent implantation in severely calcified lesions eligible for both treatment strategies (ECLIPSE): a multicentre, open-label, randomised trial.
Kirtane AJ, Généreux P, Lewis B, Shlofmitz RA, Dohad S, Choudary J, Dahle T, Pineda AM, Shunk K, Maehara A, Popma A, Redfors B, Ali ZA, Krucoff M, Armstrong E, Kandzari DE, O'Neill W, Kraemer C, Stiefel KM, Jones DE, Chambers J, Stone GW; ECLIPSE Investigators. Kirtane AJ, et al. Among authors: armstrong e. Lancet. 2025 Apr 12;405(10486):1240-1251. doi: 10.1016/S0140-6736(25)00450-7. Epub 2025 Mar 30. Lancet. 2025. PMID: 40174596 Clinical Trial.
Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial.
Brilakis ES, Edson R, Bhatt DL, Goldman S, Holmes DR Jr, Rao SV, Shunk K, Rangan BV, Mavromatis K, Ramanathan K, Bavry AA, Garcia S, Latif F, Armstrong E, Jneid H, Conner TA, Wagner T, Karacsonyi J, Uyeda L, Ventura B, Alsleben A, Lu Y, Shih MC, Banerjee S; DIVA Trial Investigators. Brilakis ES, et al. Among authors: armstrong e. Lancet. 2018 May 19;391(10134):1997-2007. doi: 10.1016/S0140-6736(18)30801-8. Epub 2018 May 11. Lancet. 2018. PMID: 29759512 Free PMC article. Clinical Trial.
Thirty-day outcomes from the Disrupt PAD BTK II study of the Shockwave Intravascular Lithotripsy System for treatment of calcified below-the-knee peripheral arterial disease.
Chandra V, Lansky AJ, Sayfo S, Shammas NW, Soukas P, Park J, Siah M, Babaev A, Shields R, West NEJ, Armstrong E. Chandra V, et al. Among authors: armstrong e. J Vasc Surg. 2025 Mar;81(3):710-719.e2. doi: 10.1016/j.jvs.2024.11.003. Epub 2024 Nov 12. J Vasc Surg. 2025. PMID: 39536842 Free article.
1,248 results